儿科瘤产品的剂量优化:我们的患者应该得到更好的治疗
Kristin M Wessel1, Nicole Drezner2, Stacy S Shord3
1United States Food and Drug Administration, Silver Spring, United States.
概括
儿童癌症药物开发正在转向向治疗,需要超出最大耐受剂量的新剂量策略. 美国食品和药物管理局 FDA
科学领域:
- 儿科瘤学 儿科瘤学
- 药物开发 药物开发
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿童癌症的生存率有所改善,但幸存者面临着严重的毒性,影响生活质量和预期寿命.
- 较新的向疗法 (例如,激酶抑制剂,抗体-药物联合体) 与传统的细胞毒性化疗相比,具有不同的疗效和安全性.
- 确定最佳的儿科癌症药物剂量对于平衡治疗有效性和耐受性至关重要.
研究的目的:
- 为了澄清美国食品和药物管理局 (FDA) 对优化儿科瘤药物剂量的观点.
- 为了解决儿科瘤学界对剂量优化的担忧.
- 确认FDA对合作努力的承诺,以开发更好的儿科癌症治疗方法.
主要方法:
- 审查传统的剂量确定试验方法 (最大耐受剂量).
- 分析瘤学药物开发向具有明显剂量反应特征的向治疗的转变.
- 考虑2024年FDA关于优化瘤产品剂量的指南.
主要成果:
- 传统的最大耐受剂量 (MTD) 方法对于新的儿童向癌症疗法是不够的.
- 美国食品和药物管理局强调定制方法来确定儿科药物剂量,考虑有效性和安全性.
- 最优计划和2024年FDA指南旨在促进优化儿科瘤学剂量.
结论:
- 需要新的策略来确定儿科瘤产品的最佳剂量,特别是向治疗.
- 美国食品和药物管理局致力于与利益相关者合作,加快开发更安全,更有效的儿科癌症药物.
- 优化剂量对于改善儿童癌症患者的治疗结果至关重要.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.8K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
相关概念视频
01:21Factors Affecting Drug Response: Overview
1.6K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.6K
01:15Drug Dosage Regimen: Overview
3.3K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.3K
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.6K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.6K
01:11Renal Failure: Dose Adjustments
34
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34
01:01Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
01:19Nonlinear Pharmacokinetics: Overview
191
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
191